The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function (Q43604506)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

B Pitt

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

B O'Neill

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R Feldman

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R Ferrari

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

L Schwartz

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

H Mudra

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

T Bass

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

C Pepine

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M Texter

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

H Haber

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

A Uprichard

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

L Cashin-Hemphill

12

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R S Lees

13

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

QUIET Study Group

14

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1058-1063

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Prognostic significance of progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Vascular affinity of trandolapril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Ongoing clinical trials of angiotensin-converting enzyme inhibitors for treatment of coronary artery disease in patients with preserved left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Identifiers

10.1016/S0002-9149(01)01461-8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43604506&oldid=2101849188"